Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004
Clomipramine Induced Neuroleptic Malignant Syndrome and Pyrexia of Unknown Origin
BMJ 329:1333-1335, Haddow,A.M.,et al, 2004
Sibutramine May Be Associated With Memory Impairment
BMJ 329:1316, Clark,D.W.J. &Harrison-Woolrych,M., 2004
Rivastigmine for Dementia Associated with Parkinson's Disease
NEJM 351:2509-2518,2547, Emre,M.,et al, 2004
Incidence of Hospitalized Rhabdomyloysis in Patients Treated With Lipid-Lowering Drugs
JAMA 292:2585-2590, Graham,D.J.,et al, 2004
Statin-Associated Exacerbation of Myasthenia Gravis
Neurol 63:2188, Cartwright,M.S.,et al, 2004
Repetition of Serotonin Syndrome After Reexposure to SSRI--A Case Report
Pharmacopsychiatry 37:236-238, Tomaselli,G. &Modestin,J., 2004
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
Clopidogrel-Associated TTP, An Update of Pharmacovigilance Efforts
Stroke 35:533-538, Zakarija,A.,et al, 2004
Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS
Neurol 62:282-284,168, Saiz,A.,et al, 2004
Tamoxifen:A New Risk Factor for Cerebral Sinus Thrombosis
Neurol 62:334-335, Masjuanh,J.,et al, 2004
Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
NEJM 350:896-903,860, Mutsch,M.,et al, 2004
Trpitans in Migraine
Neurol 62:563-568, Hall,G.C.,et al, 2004
Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004
Riversible Diffusion MRI Abnormalities and Transient Mutism after Liver Trnasplantation
Neurol 62:981-983, Bianco,F.,et al, 2004
Riluzole-Induced Neutropenia
Neurol 62:1648, Weber,G. &Bitterman,H., 2004
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004
Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004
Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004
Migraine and Other Headaches
Neurol 63:2233-2239,2209, Rose,K.M.,et al, 2004
Intrathecal Baclofen Withdrawal Mimicking Sepsis
J Emerg Med 24:423-427, Kao,L.W.,e tal, 2003
Constipation in Neurological Diseases
JNNP 74:13-19, Winge,K.,et al, 2003
Zonisamide-Induced Restless Legs Syndrome
Neurol 60:147, Chen,J.T.,et al, 2003
Use of Ephedra-containing Products and Risk for Hemorrhagic Stroke
Neurol 60:132-135, Morgenstern,L.B.,et al, 2003
Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs
Stroke 34:379-386, Bak,S.,et al, 2003
Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hospitalization for Intracerebral Hemorrhage
Stroke 34:387-391, Johnsen,S.P.,et al, 2003
Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003
Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Cortical Myoclonus During Lithium Exposure
Arch Neurol 60:401-404, Caviness,J.N.,&Evidente,V.G.H., 2003
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Neuroleptic Malignant-Like Syndrome Due to Donepezil and Maprotiline
Neurol 60:1050-1051, Ohkoshi,N.,et al, 2003
Bilateral Anterior Toxic Optic Neuropathy and the Use of Infliximab
BMJ 326:579, ten Tusscher,M.P.M.,et al, 2003
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
NEJM 348:1223-1232, 1279, Rowbotham,M.C.,et al, 2003
The Need for Regulation of Dietary Supplements-Lessons From Ephedra
JAMA 289:1568-1570, 1537, Fontanarosa,P.B.,et al, 2003
Neurological Aspects of Taste Disorders
Arch Neurol 60: 667-671, Heckmann,J.G.,et al, 2003
Severe Intoxication After Phenytoin Infusion: A Preventable Pharmacogenetic Adverse Reaction
Neurol 60:1395-1396, Citerio,G.,et al, 2003
Statin-Associated Myopathy
JAMA 289:1681-1690, Thompson,P.D.,et al, 2003
Hemi-orolingual Angioedema and ACE Inhibition After Alteplase Treatment of Stroke
Neurol 60:1525-1527,1403, Hill,M.D.,et al, 2003
Subacute Meningoencephalitis in a Subset of Patients with AD After AB42 Immunization
Neurol 61:46-54,7, Orgogozo,J.M.,et al, 2003
Stroke Associated with Sympathomimetics Contained in Over-the Counter Cough and Cold Drugs
Stroke 34:1667-1673, Cantu,C.,et al, 2003
Encephalitis Complicating Smallpox Vaccination
Arch Neurol 60:925-928, Miravalle,A. &Roos,K.L., 2003
Pathological Gambling Associated with Dopamine Agonist Therapy in Parkinson's
Neurol 61:422-423, Driver-Dunckley,E.,et al, 2003
Complementary/Alternative Medicine for Epilepsy in Arizona
Neurol 61:576-577, Sirven,J.I.,et al, 2003
Nitroglycerin-Aggravated Pre-Eclamptic Posterior Reversible Encephalopathy Syndrome (PRES)
Neurol 61:715-716, Finsterer,J.,et al, 2003
Psychiatric Adverse Events During Levetiracetam Therapy
Neurol 61:704-706, Mula,M.,et al, 2003
MR Imaging and Diffusion-Weighted Imaging Changes in Metronidazole (Flagyl)-Induced Cerebellar Toxicity
AJNR 24:1615-1617, Heaney,C.J.,et al, 2003